Close
  Indian J Med Microbiol
 

Figure 5: The changes of superoxide levels in (a) lung, (b) liver, (c) kidney, and (d) aorta at the end of experiment (at 24 h) in wild-type or SPAK knockout mice treated with lipopolysaccharide. Depicted are SPAK+/+ mice that received saline (SPAK+/+ + vehicle, n = 14) or lipopolysaccharide (SPAK+/+ + lipopolysaccharide, n = 12), SPAK+/- mice that received saline (SPAK+/- + vehicle, n = 12) or lipopolysaccharide (SPAK+/- + lipopolysaccharide, n = 12), and SPAK-/- mice that received saline (SPAK-/- +vehicle, n = 8) or lipopolysaccharide (SPAK-/- + lipopolysaccharide, n = 10). Data are expressed as mean ± standard error of mean *P < 0.05, all versus SPAK+/+ + vehicle mice; #P < 0.05, without versus with SPS1-realted proline/alanine-rich kinase in lipopolysaccharide mice. SPAK = STE20/SPS1-realted proline/alanine-rich kinase

Figure 5: The changes of superoxide levels in (a) lung, (b) liver, (c) kidney, and (d) aorta at the end of experiment (at 24 h) in wild-type or SPAK knockout mice treated with lipopolysaccharide. Depicted are SPAK<sup>+/+</sup> mice that received saline (SPAK<sup>+/+</sup> + vehicle, <i>n</i> = 14) or lipopolysaccharide (SPAK<sup>+/+</sup> + lipopolysaccharide, <i>n</i> = 12), SPAK<sup>+/-</sup> mice that received saline (SPAK<sup>+/-</sup> + vehicle, <i>n</i> = 12) or lipopolysaccharide (SPAK<sup>+/-</sup> + lipopolysaccharide, <i>n</i> = 12), and SPAK<sup>-/-</sup> mice that received saline (SPAK<sup>-/-</sup> +vehicle, <i>n</i> = 8) or lipopolysaccharide (SPAK<sup>-/-</sup> + lipopolysaccharide, <i>n</i> = 10). Data are expressed as mean ± standard error of mean *<i>P</i> < 0.05, all versus SPAK<sup>+/+</sup> + vehicle mice; <sup>#</sup><i>P</i> < 0.05, without versus with SPS1-realted proline/alanine-rich kinase in lipopolysaccharide mice. SPAK = STE20/SPS1-realted proline/alanine-rich kinase